These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 9366209

  • 1. [Ligand-induced polyubiquitination of receptor tyrosine kinases].
    Mori S.
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2284-90. PubMed ID: 9366209
    [No Abstract] [Full Text] [Related]

  • 2. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
    Schulte TW, An WG, Neckers LM.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):655-9. PubMed ID: 9367823
    [Abstract] [Full Text] [Related]

  • 3. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
    Whitesell L, Sutphin P, An WG, Schulte T, Blagosklonny MV, Neckers L.
    Oncogene; 1997 Jun 12; 14(23):2809-16. PubMed ID: 9190897
    [Abstract] [Full Text] [Related]

  • 4. Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoprotein.
    Magnifico A, Tagliabue E, Ardini E, Casalini P, Colnaghi MI, Ménard S.
    FEBS Lett; 1998 Jan 30; 422(2):129-31. PubMed ID: 9489990
    [Abstract] [Full Text] [Related]

  • 5. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM.
    Cancer Res; 2001 Feb 15; 61(4):1671-7. PubMed ID: 11245482
    [Abstract] [Full Text] [Related]

  • 6. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases.
    Sepp-Lorenzino L, Ma Z, Lebwohl DE, Vinitsky A, Rosen N.
    J Biol Chem; 1995 Jul 14; 270(28):16580-7. PubMed ID: 7622464
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway.
    Mitch WE, Goldberg AL.
    N Engl J Med; 1996 Dec 19; 335(25):1897-905. PubMed ID: 8948566
    [No Abstract] [Full Text] [Related]

  • 8. Getting activated with poly-ubiquitination.
    Depraetere V.
    Nat Cell Biol; 2001 Aug 19; 3(8):E181. PubMed ID: 11483973
    [No Abstract] [Full Text] [Related]

  • 9. SMAD destruction turns off signalling.
    Heldin CH, ten Dijke P.
    Nat Cell Biol; 1999 Dec 19; 1(8):E195-7. PubMed ID: 10587654
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association.
    Nagata Y, Anan T, Yoshida T, Mizukami T, Taya Y, Fujiwara T, Kato H, Saya H, Nakao M.
    Oncogene; 1999 Oct 28; 18(44):6037-49. PubMed ID: 10557093
    [Abstract] [Full Text] [Related]

  • 12. [Raf kinase and its inhibitory regulators].
    Guo YH, Chen GH, Tang CS.
    Sheng Li Ke Xue Jin Zhan; 2003 Jul 28; 34(3):255-8. PubMed ID: 14628476
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ubiquitin/proteasome system.
    Magnani M.
    Nat Biotechnol; 2000 Aug 28; 18(8):807. PubMed ID: 10932130
    [No Abstract] [Full Text] [Related]

  • 15. The ubiquitin-proteasome pathway: on protein death and cell life.
    Ciechanover A.
    EMBO J; 1998 Dec 15; 17(24):7151-60. PubMed ID: 9857172
    [No Abstract] [Full Text] [Related]

  • 16. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
    Goasduff T, Cederbaum AI.
    Arch Biochem Biophys; 2000 Jul 15; 379(2):321-30. PubMed ID: 10898951
    [Abstract] [Full Text] [Related]

  • 17. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.
    Jeffers M, Taylor GA, Weidner KM, Omura S, Vande Woude GF.
    Mol Cell Biol; 1997 Feb 15; 17(2):799-808. PubMed ID: 9001234
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.
    Peschard P, Park M.
    Cancer Cell; 2003 Jun 15; 3(6):519-23. PubMed ID: 12842080
    [Abstract] [Full Text] [Related]

  • 20. Failure of the ubiquitin-proteasome system in Parkinson's disease.
    McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P.
    Nat Rev Neurosci; 2001 Aug 15; 2(8):589-94. PubMed ID: 11484002
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.